Research and Development Facilities
Contract Overview
Contract Amount: $136,766,617 ($136.8M)
Contractor: Glaxosmithkline Holdings (americas) Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2007-01-17
End Date: 2017-02-06
Contract Duration: 3,673 days
Daily Burn Rate: $37.2K/day
Official Description: RESEARCH AND DEVELOPMENT FACILITIES
Place of Performance
Location: Pennsylvania, 19120